Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

Phase I Study of PM54 Administered to Patients with Advanced Solid Tumors Recruiting

2024-517579-19-00 Selected Advanced Solid Tumors 3 2025-03-24
Biodistribution Evaluation to Reduce Administered Radiopharmaceutical Dose on LOng Axial Field of VieW PET Scanners – BELOW trial Recruiting

2024-512906-24-00 Cancer 3 2025-03-21
Efficacy of Venetoclax in combination with Rituximab in Waldenström’s Macroglobulinemia Recruiting

2022-500574-34-00 Waldenström’s Macroglobulinemia 4 2025-03-21
PRESERVE-003: ONC-392 (Study Drug) Versus Docetaxel (Standard of Care) in Metastatic Non-small Cell Lung Cancer That Progressed on PD-1/PD-L… Recruiting

2023-505311-20-01 Metastatic Non-Small Cell Lung Cancer 5 2025-03-21
Ph 1 Study of ORIC-944 in Patients with Metastatic Prostate Cancer. Recruiting

2024-515527-11-00 Prostate cancer 1 2025-03-20
A clinical study of zilovertamab vedotin in people with large B-cell lymphoma (MK-2140-010) Recruiting

2024-515566-13-00 Diffuse Large B-Cell Lymphoma (DLBCL) 5 2025-03-19
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors Recruiting

2024-513285-19-00 Pancreatic Ductal Adeno Carcinoma 1 2025-03-14
A Phase I/II with Ruxolitinib in Patients with Myelofibrosis (MF) who are Unresponsive to JAK inhibitors (HEMA-MED) Recruiting

2024-515252-20-00 Myelofibrosis (MF) unresponsive to JAK inhibitors 9 2025-03-14
Vaccination against human papillomavirus (HPV) after allogeneic stem cell transplantation, a randomized study between early and late vaccina… Recruiting

2022-502912-35-00 Recipients of allogeneic stem cell transplantation 4 2025-03-12
A clinical study of MK-6070 and ifinatamab deruxtecan in people with small cell lung cancer (MK-6070-002) Recruiting

2024-517926-25-00 Small cell lung cancer 9 2025-03-12
MICROBIOTA MODIFICATION FOR IMMUNO-ONCOLOGY IN HEPATOCELLULAR CARCINOMA - “MOTHER” Recruiting

2023-508201-25-00 Hepatocellular carcinoma 4 2025-03-12
A clinical study of MK-0472 in people with solid tumors (MK-0472-001) Recruiting

2024-516006-32-00 Malignant Neoplasm - Solid Tumors 1 2025-03-11
Lutathera for the treatment of recurrent Meningioma (LUMEN-1) Recruiting

2024-513443-93-00 Recurrent Meningioma without local treatment options (S 4 2025-03-10
MEtformin as a MEtabolic iNTervention in Oesophageal adenocarcinomas to improve response to neoadjuvant chemoradiotherapy Recruiting

2024-511626-30-00 Oesophageal adenocarcinoma 4 2025-03-09
A Study of Orally Administered MOMA-313 in Participants with Advanced or Metastatic Solid Tumours Recruiting

2024-513502-62-00 Advanced or Metastatic Solid Tumors 1 2025-03-07
LYSARI – LYmphocyte-Sparing And Radio-Immunotherapy in Head and neck carcinoma - A multicenter, randomised 2*2 factorial design comparing st… Recruiting

2022-501315-13-00 Patients with lateralised oropharyngeal, laryngeal and 5 2025-03-06
Capecitabine plus pembrolizumab in patients with triple negative breast cancer after chemoimmunotherapy and surgery Recruiting

2023-505291-30-01 Triple Negative Breast Cancer with residual disease aft 4 2025-03-06
A trial to learn if AZD0486 alone or with other anticancer drugs is safe and works in adults with certain blood cancers Recruiting

2024-515034-33-00 Mantle Cell Lymphoma 9 2025-03-05
CD8 PET imaging in metastatic solid tumours; A phase II, open label, multi-center study of 89Zr-DF-crefmirlimab for CD8 positron emission to… Recruiting

2024-515885-15-00 Patients with metastatic solid tumours, where clinical 9 2025-03-04
KEYMAKER U01 Sub-Study E Signal-finding study to test investigational agents with pembrolizumab in combination with chemotherapy in newly di… Recruiting

2023-509234-19-00 Participants With Newly Diagnosed Resectable Stages II- 4 2025-03-03
Study of MK-5684-based Therapies in Advanced Prostate Cancer Recruiting

2023-506288-33-00 Metastatic castration resistant prostate cancer (mCRPC) 9 2025-03-03
A study to learn more about how well treatment with sevabertinib (BAY2927088) tablets works and how safe it is in participants who have a so… Recruiting

2024-517419-62-00 HER2 mutation 4 2025-02-28
Anti-GD2 ADC M3554 in Advanced Solid Tumors Recruiting

2024-513687-26-00 Advanced Solid Tumors 1 2025-02-25
FDG-PET/CT versus conventional CT for response monitoring in metastatic breast cancer: a multicenter randomized clinical trial (MONITOR-RCT) Recruiting

2023-508591-11-00 Metastatic breast cancer 5 2025-02-25